| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 6e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |